Published in Pharma Law Weekly, December 13th, 2005
On an operating basis the company reported a loss of $10.0 million compared with an operating loss of $1.7 million in the third quarter of 2004. The third-quarter 2005 operating loss included nonrecurring adjustments, including a lease termination fee of $4.0 million, a charge for impairment of long-lived assets of $0.8 million, and a provision of $0.7 million for excess and obsolete inventories.
The remaining change in operating loss is due to the decrease in volume and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly